Cargando…
ICAM-1-Based Rabies Virus Vaccine Shows Increased Infection and Activation of Primary Murine B Cells In Vitro and Enhanced Antibody Titers In-Vivo
We have previously shown that live-attenuated rabies virus (RABV)-based vaccines infect and directly activate murine and human primary B cells in-vitro, which we propose can be exploited to help develop a single-dose RABV-based vaccine. Here we report on a novel approach to utilize the binding of In...
Autores principales: | Norton, James E., Lytle, Andrew G., Shen, Shixue, Tzvetkov, Evgeni P., Dorfmeier, Corin L., McGettigan, James P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3906113/ https://www.ncbi.nlm.nih.gov/pubmed/24489846 http://dx.doi.org/10.1371/journal.pone.0087098 |
Ejemplares similares
-
Investigating the Role for IL-21 in Rabies Virus Vaccine-induced Immunity
por: Dorfmeier, Corin L., et al.
Publicado: (2013) -
Incorporating B cell activating factor (BAFF) into the membrane of rabies virus (RABV) particles improves the speed and magnitude of vaccine-induced antibody responses
por: Plummer, Joseph R., et al.
Publicado: (2019) -
Rabies virus glycoprotein as a carrier for anthrax protective antigen
por: Smith, Mary Ellen, et al.
Publicado: (2006) -
Circulating Intercellular Adhesion Molecule-1(ICAM-1) in Sera of Patients with Graves’ Disease and Hashimoto Disease: – The Levels of Circulating ICAM-1 Are Positively Correlates with Serum Titers of Antithyroperoxidase Antibody –
por: Lee, Jin Hong, et al.
Publicado: (1995) -
Development of in vitro and in vivo rabies virus neutralization assays based on a high-titer pseudovirus system
por: Nie, Jianhui, et al.
Publicado: (2017)